A Phase I Trial of Ad.hIFN-β Gene Therapy for Glioma
E. Antonio Chiocca(Brigham and Women's Hospital), David H. Kirn(University of Oxford), Kevin O. Lillehei(University of Colorado Health), Cheryl A. Palmer(University of Alabama at Birmingham), Allan J. Hamilton(American Cancer Society), Steven Rosenfeld(Columbia University), Katie Smith(Biogen (United States)), B. K. DeMasters(University of Colorado Health), Kevin Judy(Hospital of the University of Pennsylvania), Byron McKinney(Biogen (United States))
Cited by 118
Related Papers
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial
|The Lancet Oncology|2008|522
Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial
|Journal of neurosurgery|2003|338
Preliminary Clinical Experience with Linear Accelerator-based Spinal Stereotactic Radiosurgery
|Neurosurgery|1995|291
Loss of Miro1-directed mitochondrial movement results in a novel murine model for neuron disease
|Proceedings of the National Academy of Sciences|2014|223